Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Streptococcus pyogenes serotype M49 Formimidoylglutamase (hutG) CSB-YP468903FNH
CSB-EP468903FNH
CSB-BP468903FNH
CSB-MP468903FNH
CSB-EP468903FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Putative Holliday junction resolvase (Spy49_1750c) CSB-YP468904FNH
CSB-EP468904FNH
CSB-BP468904FNH
CSB-MP468904FNH
CSB-EP468904FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Phosphate acyltransferase (plsX) CSB-YP468905FNH
CSB-EP468905FNH
CSB-BP468905FNH
CSB-MP468905FNH
CSB-EP468905FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 30S ribosomal protein S10 (rpsJ) CSB-YP468906FNH
CSB-EP468906FNH
CSB-BP468906FNH
CSB-MP468906FNH
CSB-EP468906FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 50S ribosomal protein L29 (rpmC) CSB-YP468907FNH
CSB-EP468907FNH
CSB-BP468907FNH
CSB-MP468907FNH
CSB-EP468907FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 50S ribosomal protein L18 (rplR) CSB-YP468908FNH
CSB-EP468908FNH
CSB-BP468908FNH
CSB-MP468908FNH
CSB-EP468908FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 30S ribosomal protein S13 (rpsM) CSB-YP468909FNH
CSB-EP468909FNH
CSB-BP468909FNH
CSB-MP468909FNH
CSB-EP468909FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Aspartate--tRNA ligase (aspS), partial CSB-YP468910FNH
CSB-EP468910FNH
CSB-BP468910FNH
CSB-MP468910FNH
CSB-EP468910FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 V-type ATP synthase alpha chain (atpA), partial CSB-YP468911FNH
CSB-EP468911FNH
CSB-BP468911FNH
CSB-MP468911FNH
CSB-EP468911FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 50S ribosomal protein L34 (rpmH) CSB-YP468912FNH
CSB-EP468912FNH
CSB-BP468912FNH
CSB-MP468912FNH
CSB-EP468912FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Undecaprenyl-diphosphatase (uppP), partial CSB-YP468913FNH
CSB-EP468913FNH
CSB-BP468913FNH
CSB-MP468913FNH
CSB-EP468913FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 GTPase Der (der) CSB-YP468914FNH
CSB-EP468914FNH
CSB-BP468914FNH
CSB-MP468914FNH
CSB-EP468914FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Probable manganese-dependent inorganic pyrophosphatase (ppaC) CSB-YP468915FNH
CSB-EP468915FNH
CSB-BP468915FNH
CSB-MP468915FNH
CSB-EP468915FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Protein nrdI (nrdI) CSB-YP468916FNH
CSB-EP468916FNH
CSB-BP468916FNH
CSB-MP468916FNH
CSB-EP468916FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Oleate hydratase (sph), partial CSB-YP468917FNH
CSB-EP468917FNH
CSB-BP468917FNH
CSB-MP468917FNH
CSB-EP468917FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Enolase (eno) CSB-YP468918FNH
CSB-EP468918FNH
CSB-BP468918FNH
CSB-MP468918FNH
CSB-EP468918FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP468919FNH
CSB-EP468919FNH
CSB-BP468919FNH
CSB-MP468919FNH
CSB-EP468919FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Chorismate synthase (aroC) CSB-YP468920FNH
CSB-EP468920FNH
CSB-BP468920FNH
CSB-MP468920FNH
CSB-EP468920FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 30S ribosomal protein S16 (rpsP) CSB-YP468921FNH
CSB-EP468921FNH
CSB-BP468921FNH
CSB-MP468921FNH
CSB-EP468921FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Orotidine 5'-phosphate decarboxylase (pyrF) CSB-YP468922FNH
CSB-EP468922FNH
CSB-BP468922FNH
CSB-MP468922FNH
CSB-EP468922FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>